DA-5222: single dose administration (DA-5222 one tablet once a day)
Study summary
This study is to evaluate the effect of food on pharmacokinetics of DA-5222 in healthy adult subjects
Eligibility
Sex
ALL
Min age
19 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
* Healthy volunteers
* BMI between 18 and 30 kg/m2
* Body weight: Male≥50kg, Female≥45kg
* Subjects who have signed an informed consent themselves after receiving detailed explanation about clinical study
Exclusion Criteria:
* Subjects with clinically significant medical history
* Subjects with history of drug abuse or addicted
* Subjects with allergy or drug hypersensitivity
Primary outcome measure(s)
AUCt — pre-dose~72 hours post-dose area under the curve
Cmax — pre-dose~72 hours post-dose maximum plasma concentration
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.